About
Founder and CEO - OniX - Online Ideas Exchange Hub
OniX is an innovation and…
Articles by Martin A.
Activity
-
Breakthrough T1D pushing the frontiers on Automated Insulin Delivery for people with type 1 diabetes (T1D) and others requiring insulin. Please reach…
Breakthrough T1D pushing the frontiers on Automated Insulin Delivery for people with type 1 diabetes (T1D) and others requiring insulin. Please reach…
Liked by Martin A. Dueñas
-
Breakthrough T1D is a longstanding supporter of automated insulin delivery (AID) systems. Today’s commercially available AID systems are hybrid…
Breakthrough T1D is a longstanding supporter of automated insulin delivery (AID) systems. Today’s commercially available AID systems are hybrid…
Shared by Martin A. Dueñas
-
Inhibition of IL-11 signalling extends mammalian healthspan and lifespan For healthspan and lifespan, ERK, AMPK and mTORC1 represent critical…
Inhibition of IL-11 signalling extends mammalian healthspan and lifespan For healthspan and lifespan, ERK, AMPK and mTORC1 represent critical…
Shared by Martin A. Dueñas
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
Columbia Business School
-
Highlights/Courses: financial accounting, strategic planning and implementation, leadership
development and practices, marketing, experiential marketing, e-commerce, innovation and
entrepreneurship and negotiation skills workshop.
Team ranked # 1 and individually ranked # 2 among 100 international students in the
negotiations skills workshop
Case: ASTRA (supermarket chain in England) strategic alignment and reorganization -
-
Major: Finance and Management; Minor: Policy and Journalism
Business School Classes: management consulting (with McKinsey & Company), marketing
management, decision models, operation management and supply chain management.
Journalism School Classes: national affairs reporting (with R. Wald, former President ABC News)
Law School Classes: state & local government law, the political process and the first amendment. -
-
Publications
-
Funding Research Through the Online Partnership to Accelerate Research (OnPAR)
Journal of the American College of Cardiology: Basic to Translational Science
OnPAR—the Online Partnership to Accelerate Research—seeks to provide a second opportunity for funding of high-quality, unfunded applications originally submitted to the National Institutes of Health and other national and international funding agencies. OnPAR will match applicable, unfunded applications with the research priorities of nongovernment organizations such as private biomedical foundations, pharmaceutical companies, venture capital funds, and other private funds. Funding organization…
OnPAR—the Online Partnership to Accelerate Research—seeks to provide a second opportunity for funding of high-quality, unfunded applications originally submitted to the National Institutes of Health and other national and international funding agencies. OnPAR will match applicable, unfunded applications with the research priorities of nongovernment organizations such as private biomedical foundations, pharmaceutical companies, venture capital funds, and other private funds. Funding organization members will review and make final funding decisions through a simple, 2-step process whereby applicants can submit public abstracts directly to OnPAR. If a member requests additional information, then, by invitation only, an applicant can submit their original unfunded application and their peer review summary statement. Advancing research discovery and drug development to improve clinical outcomes for patients afflicted with or at risk for disease is the primary goal of OnPAR. OnPAR invites the scientific community to fully participate in this new funding paradigm by submitting their National Institutes of Health public abstracts so that funding members can review and potentially support these high-quality, unfunded applications.
Other authors -
-
Funding unfunded NIH research applications
Science Translational Medicine
To boost funding of promising biomedical research, Leidos—a national security, health, and engineering solutions company—in partnership with the NIH and patient advocacy organizations, is now supporting a new funding paradigm, called OnPAR (Online Partnership to Accelerate Research): a public-private partnership that seeks to provide a second funding opportunity for unfunded NIH research applications (http://onpar.leidosweb.com/ onpar/). OnPAR will seek to match investigators’ research…
To boost funding of promising biomedical research, Leidos—a national security, health, and engineering solutions company—in partnership with the NIH and patient advocacy organizations, is now supporting a new funding paradigm, called OnPAR (Online Partnership to Accelerate Research): a public-private partnership that seeks to provide a second funding opportunity for unfunded NIH research applications (http://onpar.leidosweb.com/ onpar/). OnPAR will seek to match investigators’ research applications to the specific research and development needs of nongovernment sources of funding.
Other authors -
-
Engaging Patients and Stakeholders in Scientific Peer Review of Research Applications: Lessons From PCORI’s First Cycle of Funding
The Peer Review Congress_Plenary Section Abstracts
Lessons learned from PCORI inclusion of patients and stakeholders reviewers in the organization first review of scientific applications for the first funding cycle
Other authors -
-
Therapeutic angiogenesis: a comparative study of the angiogenic potential of acidic fibroblast growth.
Journal of Vascular Surgery
Purpose: Acidic fibroblast growth factor (aFGF) is a potent mitogen for vascular and other mesenchymal cells in vitro that can induce angiogenesis in vivo. Although heparin has no mitogenic potential of its own, it is an important aFGF cofactor in vitro and may also be capable of stimulating angiogenesis. Because the development of a collateral vasculature in response to ischemia appears to be dependent on angiogenesis, we compared the abilities of aFGF with or without heparin and heparin alone…
Purpose: Acidic fibroblast growth factor (aFGF) is a potent mitogen for vascular and other mesenchymal cells in vitro that can induce angiogenesis in vivo. Although heparin has no mitogenic potential of its own, it is an important aFGF cofactor in vitro and may also be capable of stimulating angiogenesis. Because the development of a collateral vasculature in response to ischemia appears to be dependent on angiogenesis, we compared the abilities of aFGF with or without heparin and heparin alone to accelerate angiogenesis in a rat hind limb ischemia model.
Other authors -
Courses
-
Financial Management, Economics, Decision Models, and Accounting
5
-
First Amendment Law, State and Local Policy
2
-
Journalism
2
-
Knowledge Management, and Biotech
3
-
Management Consultant with McKinsey
1
-
Operation Management
1
-
Public Administration
1
Projects
-
Grants and Contracts, and Contact Relationship Management System
Development and Implementation of Grants and Contact Relationship management system to manage a budget of over $500M annually for PCORI. The system includes the following modules: Pre-Award Management: Program Announcement, Letters of Intent, Applications, Reviewers, Online and In-Person Scoring, and Post-Awad Management: Activation, Reporting, Auditing, Publications, and others.
Other creators -
-
Helpdesk
Development and Implementation of a helpdesk that answered inquires in the range of 20 - 200 per day. All inquires were successfully resolved within organization's guidelines and timelines. We used ZenDesk as the main ticketing services to log, track, answer, and analysis of all inquires.
Other creators -
-
Web-based Grants Management System
Concept, Development and Implementation of a web-based grants management system that supported over 2,000 national and international grantees, and over 90 national and multiple international offices for communication and fundraising for JDRF.
Other creators -
-
NYU Medical School Business Process reengeneering of Post-Award Management
Identify; Review, Update, and Analyze; Design; Test and Implement the entire Post-Award Management Division for the $250M grants portfolio of the School of Medicine.
Other creators -
-
Patients and Stakeholders Reviewers and Mentor Program
-
Development of a training program for Patients and Stakeholder to support the Merit Review process at PCORI. In addition, development and implementation of a Patients and Stakeholder Mentor program to (1) support the patient-stakeholder reviewer, (2) to serve as PCORI ambassador, and (3) to participate in the research enterprise from concept through proposal development and dissemination of findings.
Other creators -
-
PCORI Pre-Award Management Infrastructure
-
Development, implementation, and sustainment of PCORI Pre-Award Management Infrastructure. These included preparation and launching of all program announcements: Assessment of Prevention, Diagnosis, and Treatment Options; Improving Healthcare Systems; Communication and Dissemination Research; Addressing Disparities; Improving Methods for Conducting Patient-Centered Outcomes Research; Improving Infrastructure for Conducting Patient Centered Outcomes Research: Phase One —Clinical Data Research…
Development, implementation, and sustainment of PCORI Pre-Award Management Infrastructure. These included preparation and launching of all program announcements: Assessment of Prevention, Diagnosis, and Treatment Options; Improving Healthcare Systems; Communication and Dissemination Research; Addressing Disparities; Improving Methods for Conducting Patient-Centered Outcomes Research; Improving Infrastructure for Conducting Patient Centered Outcomes Research: Phase One —Clinical Data Research Networks; Improving Infrastructure for Conducting Patient Centered Outcomes Research: Phase One —Patient-Powered Research Networks; and others. In addition, development and implementation of pre-award policies and procedures; and training of applicants, reviewers, patients/stakeholders, and PCORI internal staff.
Other creators -
-
Start-up
-
Founding team member leading and managing the creation of PCORI as a funding organization. Lead the development and implementation of web- and cloud-based grants and contact relationship management system. Lead the entire funding cycle from the creation of the program funding announcement, through the letters of intent and application process, the final review process, and the recruitment and training of hundreds of scientists, patients, and stakeholders. Lead all IT initiatives, support of…
Founding team member leading and managing the creation of PCORI as a funding organization. Lead the development and implementation of web- and cloud-based grants and contact relationship management system. Lead the entire funding cycle from the creation of the program funding announcement, through the letters of intent and application process, the final review process, and the recruitment and training of hundreds of scientists, patients, and stakeholders. Lead all IT initiatives, support of the organization strategic plan, train of new staff, support of board committees and board of governors, and others.
Other creators -
-
Venture philanthropy management
-
Managed the industry (biotech, pharma) partnerships for the organization:
- Developed standard operating procedures
- Work with counsel to develop contracts and policies and procedures
- manage contract reporting, payments, evaluations and auditingOther creators -
-
Grants Policies and Procedures
-
Updated the organization Grants Policies and Procedures including:
- Policy Requirements
- Payments
- Cost Considerations
- Administrative Requirements
- Monitoring and Reporting
- Enforcement ActionsOther creators -
-
Grants/Contracts Standard Operating Procedures
-
Updated the grants and contracts standard operating procedures including:
- Pre-Award: Program Development and Implementation, Applications Submission and Review, Award Approval;
- Post-Award: Reporting, Auditing, Evaluation, Renewals, No-Cost Extension, Carry-overs, Budget Updates, Supplements, Transfers;
- Grants Management System: Reporting, Publication submission, Evaluation
- Risk Management: Implemented risk management strategyOther creators -
Languages
-
Spanish
-
Recommendations received
-
LinkedIn User
1 person has recommended Martin A.
Join now to viewOther similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More